Fresenius SE & Co KGaA (FRA:FRE) Given a €52.00 Price Target by HSBC Analysts

Fresenius SE & Co KGaA (FRA:FRE) received a €52.00 ($60.47) price target from HSBC in a report released on Thursday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. HSBC’s target price suggests a potential upside of 19.91% from the stock’s current price.

A number of other research analysts also recently commented on the company. Morgan Stanley set a €50.00 ($58.14) price target on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a report on Monday, September 30th. Credit Suisse Group set a €50.00 ($58.14) price target on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a report on Thursday, July 18th. Nord/LB set a €58.00 ($67.44) price target on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Wednesday, July 31st. Warburg Research set a €65.00 ($75.58) price target on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Friday, July 26th. Finally, JPMorgan Chase & Co. set a €58.40 ($67.91) price target on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Thursday. Nine investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of €57.93 ($67.36).

Shares of FRA FRE opened at €43.37 ($50.42) on Thursday. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02). The business has a 50-day moving average of €43.63 and a 200-day moving average of €46.49.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Read More: What are earnings reports?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.